Philippines SEC Directs Google, Apple to Delist Binance App Over Investor Security Concerns 
Tesla Nears FSD Licensing Deal with Major Automaker, Hits 1.3 Billion Milestone 
Bitcoin Surges Past Tesla in Five-Year Gains, Sparks New Interest in ETFs 
US Supreme Court Signals Support for Starbucks in Landmark Labor Law Case 
Asahi Kasei to Build EV Battery Plant in Canada to Supply Key Parts to Honda Motor 
Starbucks Drops Limited-Edition Motto Frappuccino in Japan Stores 
Tesla Wipes Out New Content Marketing Unit, Fired All Team Members 
Crypto.com's Launch in South Korea Stalled by AML Regulatory Concerns, Postponement Announced 
SK Networks Sets Up AI Research Lab in Silicon Valley 
Tesla to Lay Off 2,700 in Austin, Over 3,300 in California Under Restructuring Scheme 
Volvo Cars Projects Robust Demand Despite Financial Hiccups in Q1 
Coca-Cola, Microsoft Forge $1.1B Alliance for Cloud and AI Innovation 
Tesla Reveals Plans to Release New EVs Earlier Than Scheduled, to Introduce Cheaper Models 
Amazon to Introduce Air Delivery Service in Arizona via Drone 
7-Eleven Reveals Global Growth Plan to Boost Its F&B Programs 
LG Energy Solution to Combat Infringement By Launching Licensing Business for Battery Patents 
Visa's Q2 Earnings Surpass Expectations, Fueled by Consumer Spending 
SAN DIEGO, Feb. 02, 2018 -- After Tuesday’s State of the Union Address, The Recover examines Trump’s message to lower prescription costs and fight for the dying rights of those with terminal conditions.
|
|||||
In his speech he addressed the “Right to Try” Legislation that was proposed but is waiting on approval from the FDA. "We also believe that patients with terminal conditions should have access to experimental treatments that could potentially save their lives," the president said.
"People who are terminally ill should not have to go from country to country to seek a cure — I want to give them a chance right here at home. It is time for the Congress to give these wonderful Americans the 'right to try,'" he says.
The prescription drug cost has been rising in recent years, with medications dramatically increasing 44% since 2003, and continues to grow with out interference. Trump proposes to prevent that from happening under his administration, but without a clear plan.
"One of my greatest priorities is to reduce the price of prescription drugs. In many other countries, these drugs cost far less than what we pay in the United States," Trump stated.
"And it is very, very unfair," he said. "That is why I have directed my administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down."
The President will also have to address the issue that some of these prescription drugs have led to the opioid problem the country faces. Other pain relievers and stimulant prescription drugs can be misused and can cause an addiction to the user.
Alex Azar was in attendance at the address, a former drug company executive, lobbyist and spokesperson who has been sworn in as Secretary of Health and Human Services under President Trump's cabinet. Mr. Azar’s former profession brings into question how someone from that industry could possibly have a hand in disrupting their profit and helping the people of America. While introducing Azar, Trump mentioned several times that he shared his desire in reducing prescription drug prices.
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave 101a, Temecula, CA 92590
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cf3a285e-8af4-4ac2-89ce-40e8b07cda15
